ClaimBuddy gains $3 million in their pre-Series A round

Healthtech startup ClaimBuddy has successfully raised $3 million in their pre-Series A funding round co-led by Chiratae Ventures and Rebright Partners.

Healthtech startup ClaimBuddy has successfully raised $3 million in their pre-Series A funding round co-led by Chiratae Ventures and Rebright Partners. Previous investors Titan Capital & Relentless Ventures along with some angel investors also participated in the round. The funds were used in the domains of sales, technology and marketing.

Started by IIM Banglore alumni, Khet Singh and Ajit Patel, the venture provides a digital infrastructure to hospitals to help process the patient’s insurance claims. The startup claims to leverage technology to act as a one-stop solution for processing insurance cover.

The company claims to have so far helped process claims worth more than Rs 100 crore for over 7200 patients. They had previously raised an undisclosed seed fund from Titan Capital and LV angel fund, First Cheque and a few angel investors. Since their inception, they have partnered with more than 125 hospitals in more than 6 cities. In the past year, they saw a 10x growth and would the current funds to smoother the process. 

Over 90% of hospitals in India are individually owned. They usually lack the required technology and domain expertise to manage insurance. This often results in delays, deductions or worse rejections of the patients’ health insurance claims.

Tags : #ClaimBuddy #KhetSingh #AjitPatel #ChirataeVentures #RebrightPartners #TitanCapital #RelentlessVentures #Insurtech #IIM #funding #fundingalert #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Antibiotics Are Not Always the Answer: Understanding Viral Infections and Responsible Medication UseJanuary 02, 2025
Medical Emergencies Are Above Rules: What This Delhi HC Verdict Means for YouJanuary 02, 2025
Is Your Uterus Safe? The Disturbing Trends in Women’s Health Across IndiaJanuary 02, 2025
India’s Pharma Industry Faces New Regulatory Storm: Will Drugmakers Adapt to Schedule M?January 02, 2025
From Vision to Value: Inside Dr. Agarwal Health Care’s Market-Dominating IPOJanuary 02, 2025
5 Ways to Help Relieve Constipation in Babies at HomeDecember 30, 2024
10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024